P. H. Cox

475 total citations
33 papers, 336 citations indexed

About

P. H. Cox is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, P. H. Cox has authored 33 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Radiology, Nuclear Medicine and Imaging, 13 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in P. H. Cox's work include Radiopharmaceutical Chemistry and Applications (13 papers), Medical Imaging and Pathology Studies (8 papers) and Medical Imaging Techniques and Applications (5 papers). P. H. Cox is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (13 papers), Medical Imaging and Pathology Studies (8 papers) and Medical Imaging Techniques and Applications (5 papers). P. H. Cox collaborates with scholars based in Netherlands, United Kingdom and Germany. P. H. Cox's co-authors include A. Logmans, J. Baptist Trimbos, Hein G. de Bruin, R. H. Kruyt, Van Tsai, Suresh D. Sharma, Jack S. Remington, Fausto G. Araujo, Brett L. Shapiro and J Frühling and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Infection and Immunity.

In The Last Decade

P. H. Cox

28 papers receiving 305 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P. H. Cox Netherlands	10	121	90	83	69	41	33	336
P. Skaarup Denmark	12	45 0.4×	232 2.6×	77 0.9×	56 0.8×	29 0.7×	49	523
Luciano Paladini Brazil	8	100 0.8×	96 1.1×	97 1.2×	213 3.1×	50 1.2×	20	526
Ackerman Nb United States	10	48 0.4×	96 1.1×	208 2.5×	146 2.1×	68 1.7×	32	501
J Fettich Slovenia	11	90 0.7×	151 1.7×	102 1.2×	21 0.3×	127 3.1×	27	522
S. F. Grebe Germany	6	97 0.8×	152 1.7×	66 0.8×	42 0.6×	38 0.9×	19	308
N Molea Italy	9	73 0.6×	108 1.2×	140 1.7×	136 2.0×	45 1.1×	35	451
Carlos N. Rios United States	6	84 0.7×	48 0.5×	86 1.0×	63 0.9×	28 0.7×	9	342
Woo Kyung Chung South Korea	9	124 1.0×	174 1.9×	80 1.0×	61 0.9×	65 1.6×	18	422
Merrill A. Bender United States	12	211 1.7×	182 2.0×	118 1.4×	123 1.8×	78 1.9×	22	595
Antonio Rodríguez-Antúnez United States	11	135 1.1×	165 1.8×	148 1.8×	77 1.1×	29 0.7×	33	448

Countries citing papers authored by P. H. Cox

Since Specialization

Citations

This map shows the geographic impact of P. H. Cox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. H. Cox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. H. Cox more than expected).

Fields of papers citing papers by P. H. Cox

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. H. Cox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. H. Cox. The network helps show where P. H. Cox may publish in the future.

Co-authorship network of co-authors of P. H. Cox

This figure shows the co-authorship network connecting the top 25 collaborators of P. H. Cox. A scholar is included among the top collaborators of P. H. Cox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. H. Cox. P. H. Cox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

George, Suzanne, Jean‐Yves Blay, Ping Chi, et al.. (2024). The INSIGHT study: a randomized, Phase III study of ripretinib versus sunitinib for advanced gastrointestinal stromal tumor with KIT exon 11 + 17/18 mutations. Future Oncology. 20(27). 1973–1982. 4 indexed citations

Logmans, A., et al.. (1999). Lymphedema and Lymphocysts Following Lymphadenectomy May Be Prevented by Omentoplasty: A Pilot Study. Gynecologic Oncology. 75(3). 323–327. 55 indexed citations

Cox, P. H., et al.. (1996). Tc-99m tetrofosmin myocardial distribution 4 hours post injection. International journal of cardiac imaging. 12(2). 127–135. 3 indexed citations

Cox, P. H.. (1993). Criteria for the use of monoclonal antibodies, legislation and ethical considerations. Nuclear Medicine Communications. 14(8). 653–657.

Markusse, H. M., et al.. (1992). A Quantitative Index Derived from 99mTc-Pertechnetate Scintigraphy to Assist in the Diagnosis of Primary Sjogren’s Syndrome. Nuklearmedizin - NuclearMedicine. 31(1). 3–6. 6 indexed citations

Cox, P. H., et al.. (1990). Report and recommendations on the requirements for postgraduate training in radiopharmacy and radiopharmaceutical chemistry 1989. European Journal of Nuclear Medicine and Molecular Imaging. 17(5). 203–211. 1 indexed citations

Cox, P. H., et al.. (1990). Uterine radiation dose from open sources: the potential for underestimation. European Journal of Nuclear Medicine and Molecular Imaging. 17(1-2). 94–95. 5 indexed citations

Planting, André, et al.. (1990). Radioimmunodetection in rhabdo- and leiomyosarcoma with 111In-anti-myosin monoclonal antibody complex.. PubMed. 50(3 Suppl). 955s–957s. 3 indexed citations

Cox, P. H., et al.. (1988). The stability of 99mTc-DTPA and 99mTc-HIDA following ultrasonic nebulisation. European Journal of Nuclear Medicine and Molecular Imaging. 14-14(7-8). 400–2. 1 indexed citations

10.

Cox, P. H., et al.. (1988). Indium111 antimyosin for the detection of leiomyosarcoma and rhabdomyosarcoma. European Journal of Nuclear Medicine and Molecular Imaging. 14(1). 50–2. 12 indexed citations

11.

Cox, P. H., et al.. (1987). A high efficiency ultrasound nebuliser for radioaerosol studies of the lungs. European Journal of Nuclear Medicine and Molecular Imaging. 13(7). 331–4. 5 indexed citations

12.

Rezvani, M., et al.. (1987). Changes in pulmonary mean transit time demonstrated by the scintigraphic first pass technique in patients receiving radiation therapy. European Journal of Nuclear Medicine and Molecular Imaging. 13(6). 305–6. 4 indexed citations

13.

Frühling, J, Pierre Bourgeois, & P. H. Cox. (1983). Axillary lymphoscintigraphy: Current status in the treatment of breast cancer. Critical Reviews in Oncology/Hematology. 1(1). 1–20. 12 indexed citations

14.

Araujo, Fausto G., Suresh D. Sharma, Van Tsai, P. H. Cox, & Jack S. Remington. (1982). Monoclonal antibodies to stages of Trypanosoma cruzi: characterization and use for antigen detection. Infection and Immunity. 37(1). 344–349. 26 indexed citations

15.

Cox, P. H., et al.. (1977). A comparison between phlebography, radioisotope venography, and 99mTc Urokinase scintigraphy for the detection of deep vein thrombosis. European Journal of Nuclear Medicine and Molecular Imaging. 2(1). 19–22. 1 indexed citations

16.

Cox, P. H., et al.. (1976). VISUALISATION OF THROMBI WITH TECHNETIUM-99m UROKINASE. The Lancet. 308(7985). 572–573.

17.

Cox, P. H., et al.. (1976). Thallium 201 chloride uptake in tumours, a possible complication in heart scinitigraphy. British Journal of Radiology. 49(585). 767–768. 59 indexed citations

18.

Cox, P. H., et al.. (1976). ¹²⁵Iodinated fibrinogen uptake in inflammatory joint disease as a complicating factor in the detection of deep vein thrombosis. British Journal of Radiology. 49(580). 348–350. 3 indexed citations

19.

Cox, P. H.. (1974). ⁹⁹Tc^mcomplexes for skeletal scintigraphy. Physico-chemical factors affecting bone and bone-marrow uptake. British Journal of Radiology. 47(564). 845–850. 22 indexed citations

20.

Cox, P. H., et al.. (1968). The distribution of small concentrations of active ingredients in tablet granules. Journal of Pharmacy and Pharmacology. 20(3). 238–239. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact